| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis C Bombardier, L Laine, A Reicin, D Shapiro, R Burgos-Vargas, B Davis, ... New England Journal of Medicine 343 (21), 1520-1528, 2000 | 5519 | 2000 |
| Clinical pharmacokinetics of metformin GG Graham, J Punt, M Arora, RO Day, MP Doogue, JK Duong, TJ Furlong, ... Clinical pharmacokinetics 50 (2), 81-98, 2011 | 1606 | 2011 |
| Nonsteroidal antiinflammatory drugs—differences and similarities PM Brooks, RO Day New England Journal of Medicine 324 (24), 1716-1725, 1991 | 1402 | 1991 |
| Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis AG Johnson, TV Nguyen, RO Day Annals of internal medicine 121 (4), 289-300, 1994 | 1100 | 1994 |
| Association of interruptions with an increased risk and severity of medication administration errors JI Westbrook, A Woods, MI Rob, W Dunsmuir, RO Day Archives of Internal medicine 170 (8), 683-690, 2010 | 1070 | 2010 |
| The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings GG Graham, MJ Davies, RO Day, A Mohamudally, KF Scott Inflammopharmacology 21 (3), 201-232, 2013 | 862 | 2013 |
| Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials GC Machado, CG Maher, PH Ferreira, MB Pinheiro, CWC Lin, RO Day, ... bmj 350, 2015 | 826 | 2015 |
| Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor NM Davies, AJ McLachlan, RO Day, KM Williams Clinical pharmacokinetics 38 (3), 225-242, 2000 | 555 | 2000 |
| CareTrack: assessing the appropriateness of health care delivery in Australia WB Runciman, TD Hunt, NA Hannaford, PD Hibbert, JI Westbrook, ... Medical Journal of Australia 197 (2), 100-105, 2012 | 540 | 2012 |
| Effects of allopurinol on the progression of chronic kidney disease SV Badve, EM Pascoe, A Tiku, N Boudville, FG Brown, A Cass, P Clarke, ... New England Journal of Medicine 382 (26), 2504-2513, 2020 | 511 | 2020 |
| Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis CA Shaheed, CG Maher, KA Williams, R Day, AJ McLachlan JAMA internal medicine 176 (7), 958-968, 2016 | 510 | 2016 |
| Researchers’ views on, and experiences with, the requirement to obtain informed consent in research involving human participants: A qualitative study A Xu, MT Baysari, SL Stocker, LJ Leow, RO Day, JE Carland BMC medical ethics 21 (1), 93, 2020 | 507 | 2020 |
| Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial CM Williams, CG Maher, J Latimer, AJ McLachlan, MJ Hancock, RO Day, ... The Lancet 384 (9954), 1586-1596, 2014 | 457 | 2014 |
| Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects X Jiang, KM Williams, WS Liauw, AJ Ammit, BD Roufogalis, CC Duke, ... British journal of clinical pharmacology 57 (5), 592-599, 2004 | 424 | 2004 |
| Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review MH Reckmann, JI Westbrook, Y Koh, C Lo, RO Day Journal of the American Medical Informatics Association 16 (5), 613-623, 2009 | 383 | 2009 |
| Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 P Brooks, P Emery, JF Evans, H Fenner, CJ Hawkey, C Patrono, J Smolen, ... Rheumatology 38 (8), 779, 1999 | 376 | 1999 |
| A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients? MHH Lee, GG Graham, KM Williams, RO Day Drug Safety 31 (8), 643-665, 2008 | 367 | 2008 |
| Stereoselective disposition of ibuprofen enantiomers in man EJD Lee, KM Williams, R Day, G Graham, D Champion British journal of clinical pharmacology 58 (7), S759-S764, 2004 | 362* | 2004 |
| A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis R Day, B Morrison, A Luza, O Castaneda, A Strusberg, M Nahir, ... Archives of internal medicine 160 (12), 1781-1787, 2000 | 355 | 2000 |
| Non-steroidal anti-inflammatory drugs (NSAIDs) RO Day, GG Graham BMJ 346, f3195, 2013 | 349 | 2013 |
Graham GarryProfessor of Pharmacology, University of New South WalesVerified email at unsw.edu.au
